Use of central nervous system drugs in combination with selective serotonin reuptake inhibitor treatment: A Bayesian screening study for risk of suicidal behavior

Use of central nervous system drugs in combination with selective serotonin reuptake inhibitor treatment: A Bayesian screening study for risk of suicidal behavior

BackgroundUsing other central nervous system (CNS) medications in combination with selective serotonin reuptake inhibitor (SSRI) treatment is common. Despite this, there is limited evidence on the impact on suicidal behavior of combining specific medications. We aim to provide evidence on signals fo...

Full description

Bibliographic Details
Main Authors: Tyra Lagerberg, Arvid Sjölander, Robert D. Gibbons, Patrick D. Quinn, Brian M. D’Onofrio, Clara Hellner, Paul Lichtenstein, Seena Fazel, Zheng Chang
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-11-01
Series:Frontiers in Psychiatry
Subjects:
screening study
selective serotonin reuptake inhibitor
suicidal behavior
central nervous system drugs
Bayesian
Online Access:https://www.frontiersin.org/articles/10.3389/fpsyt.2022.1012650/full

Internet

https://www.frontiersin.org/articles/10.3389/fpsyt.2022.1012650/full

Similar Items